![Peter Clinton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Peter Clinton
Società | Posizione | Inizio | Fine |
---|---|---|---|
Amprion, Inc.
![]() Amprion, Inc. Medical SpecialtiesHealth Technology Amprion, Inc. is a company based in San Diego, CA that specializes in biomarker testing for brain diseases. The American company's Syntap® biomarker test aids physicians in the clinical diagnosis of Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The test identifies misfolded synuclein aggregates, a hallmark in various neurodegenerative diseases. Amprion plans to launch other biomarker tests to detect Alzheimer's in early stages. The company was founded in 2006 by Claudio Soto and Russ M. Lebovitz, who has been the CEO since then. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Peter Clinton
Precedenti posizioni note di Peter Clinton
Società | Posizione | Inizio | Fine |
---|---|---|---|
Cricket Wellington, Inc. | Amministratore Delegato | 09/12/2011 | - |
Statistiche
Distribuzione geografica
Nuova-Zelanda | 2 |
Stati Uniti | 2 |
Posizioni
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Cricket Wellington, Inc. | |
Amprion, Inc.
![]() Amprion, Inc. Medical SpecialtiesHealth Technology Amprion, Inc. is a company based in San Diego, CA that specializes in biomarker testing for brain diseases. The American company's Syntap® biomarker test aids physicians in the clinical diagnosis of Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The test identifies misfolded synuclein aggregates, a hallmark in various neurodegenerative diseases. Amprion plans to launch other biomarker tests to detect Alzheimer's in early stages. The company was founded in 2006 by Claudio Soto and Russ M. Lebovitz, who has been the CEO since then. | Health Technology |
- Borsa valori
- Insiders
- Peter Clinton
- Esperienza